Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sex Transm Dis ; 49(1): e34-e36, 2022 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-33993159

RESUMEN

ABSTRACT: Herpes zoster is an acute, cutaneous viral infection caused by the reactivation of varicella-zoster virus. Genital dermatomes are involved in only up to 2% of cases and are probably underrecognized. We present a series of 7 genital herpes zoster cases diagnosed in our Unit of Sexually Transmitted Diseases. None of our patients were positive for HIV test, and only one was taking immunosuppressive medication. We recommend the use of molecular testings to confirm the diagnosis of varicella-zoster virus or herpes simplex virus infection in all cases of genital herpes-like lesions.


Asunto(s)
Herpes Genital , Herpes Simple , Herpes Zóster , Genitales , Herpes Genital/diagnóstico , Herpes Genital/tratamiento farmacológico , Herpes Simple/diagnóstico , Herpes Zóster/diagnóstico , Herpes Zóster/tratamiento farmacológico , Herpesvirus Humano 3 , Humanos
2.
Dermatol Ther ; 33(4): e13540, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32385947

RESUMEN

Sonic hedgehog pathway inhibitor Vismodegib is the first systemic treatment to be approved for metastatic or locally advanced basal cell carcinoma non-subsidiary of surgical treatment, and appears to be a promising treatment option for patients with nevoid basal cell carcinoma syndrome. In these patients, where repeated or prolonged treatment may be necessary, the psychological exhaustion caused by the chronicity of less severe adverse effects appears as the main limiting factor in the persistence of the drug in the long term and in the willingness of patients to take the drug again after its suspension. We report our experience with three cases where a drug holiday approach was effective in decreasing the intensity of adverse effects or improving the patient's subjective tolerance to the drug while maintaining clinical response.


Asunto(s)
Antineoplásicos , Síndrome del Nevo Basocelular , Carcinoma Basocelular , Preparaciones Farmacéuticas , Neoplasias Cutáneas , Anilidas/efectos adversos , Antineoplásicos/efectos adversos , Síndrome del Nevo Basocelular/diagnóstico , Síndrome del Nevo Basocelular/tratamiento farmacológico , Carcinoma Basocelular/tratamiento farmacológico , Proteínas Hedgehog/uso terapéutico , Humanos , Piridinas , Neoplasias Cutáneas/tratamiento farmacológico
3.
Contact Dermatitis ; 82(2): 83-86, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31515812

RESUMEN

BACKGROUND: Since 2009, an increasing number of published cases of allergic contact dermatitis (ACD) from isothiazolinones in Europe was observed, amounting to an epidemic. However, only few studies have assessed the current situation after changes in European regulation. OBJECTIVES: To analyze the incidence of isothiazolinone-related ACD in our area in the last decade. METHODS: A retrospective study analyzed all patients patch tested in the allergy unit in a tertiary hospital in Spain between January 2010 and June 2019. Positive patch-test reactions to methylchloroisothiazolinone (MCI)/methylisothiazolinone (MI) and/or MI alone were recorded. RESULTS: A total of 243 patients (9.55%) with positive patch-test reactions to MCI/MI and/or MI alone among 2544 consecutively patch-tested patients were recorded. An initial increase in the prevalence of MCI/MI allergy was observed, from 4.5% in 2010 reaching a peak in 2015, which was followed by a significant decrease until July 2019 with 3.1% prevalence in 2019. CONCLUSIONS: As shown in our data, regulatory interventions have resulted in a dramatic decrease in the prevalence of MCI and MI ACD, reaching a pre-epidemic level of 3.1% in 2019.


Asunto(s)
Dermatitis Alérgica por Contacto/epidemiología , Dermatitis Profesional/epidemiología , Conservadores Farmacéuticos/efectos adversos , Tiazoles/efectos adversos , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Profesional/diagnóstico , Dermatitis Profesional/etiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas del Parche/estadística & datos numéricos , Prevalencia , Estudios Retrospectivos , España
4.
Australas J Dermatol ; 61(3): e351-e353, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32141075

RESUMEN

Chlorpromazine is known to produce both systemic phototoxic and photoallergic reactions. However, it may also cause photoallergic contact dermatitis and, albeit exceptionally, allergic contact dermatitis (ACD). We present a series of photoallergic contact dermatitis and ACD to chlorpromazine diagnosed at a tertiary centre cutaneous allergy unit between 1980 and 2019.


Asunto(s)
Antipsicóticos/efectos adversos , Clorpromazina/efectos adversos , Dermatitis Fotoalérgica/etiología , Adulto , Queilitis/inducido químicamente , Párpados , Dermatosis Facial/inducido químicamente , Femenino , Dedos , Dermatosis de la Mano/inducido químicamente , Humanos , Persona de Mediana Edad , Pruebas del Parche , Estudios Retrospectivos
5.
Australas J Dermatol ; 61(2): e223-e225, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31766073

RESUMEN

Dupilumab, a biologic drug approved for the treatment of moderate-to-severe atopic dermatitis, has been associated with resolution or improvement in pre-existing alopecia areata. We report a case of significant improvement of AA after Dupilumab-onset treatment for atopic dermatitis and review the literature.


Asunto(s)
Alopecia Areata/tratamiento farmacológico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Dermatitis Atópica/tratamiento farmacológico , Adulto , Alopecia Areata/complicaciones , Dermatitis Atópica/complicaciones , Estudios de Seguimiento , Humanos , Masculino , Resultado del Tratamiento
6.
Australas J Dermatol ; 61(2): 105-109, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31731325

RESUMEN

BACKGROUND/OBJECTIVES: Several studies have reported that non-alcoholic fatty liver disease (NAFLD) is more frequent in patients with psoriasis, but few have reviewed the presence of liver fibrosis in those patients. METHODS: Cross-sectional cohort, single-centre study, continuously selecting all patients with moderate-severe psoriasis seen at the Psoriasis Unit of a Tertiary Hospital. The grade of liver steatosis was assessed using liver ultrasound, and the quantity of liver fibrosis was graded using a transitional vibration-controlled elastography (Fibroscan®). RESULTS: A total of 71 patients (66.2% male) were included, with an average age of 46.6 years old. The maximum historical PASI average was 14.4 while the baseline PASI average at the time of the study was 2. A third (36%) of patients met the criteria for metabolic syndrome 52% of patients had steatosis; being male, having metabolic syndrome comorbidities, elevated AST/ALT enzymes, dyslipidemia and high initial PASI were significantly related. 14% of patients had moderate liver fibrosis (≥7.6 KPa). In 30% of them, no ultrasound liver steatosis was observed. CONCLUSIONS: Elastography may be a useful tool along with ultrasound to evaluate liver disease in patients with psoriasis.


Asunto(s)
Diagnóstico por Imagen de Elasticidad , Enfermedad del Hígado Graso no Alcohólico/diagnóstico por imagen , Enfermedad del Hígado Graso no Alcohólico/etiología , Psoriasis/complicaciones , Adulto , Estudios de Cohortes , Estudios Transversales , Femenino , Humanos , Masculino , Síndrome Metabólico/etiología , Persona de Mediana Edad
8.
Am J Dermatopathol ; 41(4): 289-292, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30252698

RESUMEN

We report the case of a 32-year-old man with measles in which skin biopsy helped to establish a definitive diagnosis. Follicular involvement is a common histopathologic feature of measles. Multinucleated epidermal and follicular cells are distinctive findings.


Asunto(s)
Células Gigantes/patología , Folículo Piloso/patología , Queratinocitos/patología , Sarampión/patología , Glándulas Sebáceas/patología , Adulto , Biopsia , Humanos , Masculino , Sarampión/diagnóstico
9.
Am J Dermatopathol ; 41(10): 744-746, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31094720

RESUMEN

The differential diagnosis of Grover disease (GD) includes pemphigus foliaceus. However, the focal nature of the histologic findings and negative direct immunofluorescent point to the diagnosis of GD. It has been associated with a variety of systemic and cutaneous diseases, but its association with other primary acantholytic disorders has been rarely documented. In this article, we describe the first case of GD in association with pemphigus foliaceus.


Asunto(s)
Acantólisis/complicaciones , Carcinoma Basocelular/complicaciones , Ictiosis/complicaciones , Pénfigo/complicaciones , Neoplasias Cutáneas/complicaciones , Carcinoma Basocelular/cirugía , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Cutáneas/cirugía
10.
Dermatol Online J ; 25(9)2019 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-31738845

RESUMEN

Programmed cell death receptor 1 inhibitors (anti-PD-1) constitute a form of immunotherapy for the treatment of several cancers. They are associated with cutaneous immune-related adverse events (irAE), occurring in up to 50% of patients. Lichenoid dermatitis is frequent and several presentations have been described. Although attempts have been made to study these reactions, they are yet to be fully characterized and the relationship with tumor response is unclear. We describe a case of digital ulcerative lichenoid dermatitis resembling ulcerative cutaneous lichen planus that occurred during pembrolizumab therapy for oral squamous cell carcinoma. The patient developed a painful ulcer on his index finger 18 months into therapy. Biopsy revealed epidermal ulceration with intense lichenoid dermatitis. Immunohistochemical study revealed intense CD8 positivity at the ulcer's edges and marked CD163 positivity at its base. Although idiopathic forms of this type of lichenoid dermatitis are particularly recalcitrant, our case was successfully managed with topical therapy and oncologic treatment did not require modification. One year after ending treatment the patient remains free of disease progression. It is unclear if this reaction is associated with his favorable oncologic response. This report adds an undescribed reaction to the increasing diversity of cutaneous irAE associated with anti-PD-1 therapy.


Asunto(s)
Anticuerpos Monoclonales Humanizados/efectos adversos , Antineoplásicos Inmunológicos/efectos adversos , Erupciones Liquenoides/inducido químicamente , Receptor de Muerte Celular Programada 1/antagonistas & inhibidores , Úlcera Cutánea/inducido químicamente , Administración Cutánea , Anciano , Anticuerpos Monoclonales Humanizados/uso terapéutico , Antineoplásicos Inmunológicos/uso terapéutico , Betametasona/administración & dosificación , Betametasona/análogos & derivados , Carcinoma de Células Escamosas/tratamiento farmacológico , Combinación de Medicamentos , Gentamicinas/administración & dosificación , Humanos , Erupciones Liquenoides/tratamiento farmacológico , Erupciones Liquenoides/patología , Masculino , Neoplasias de la Boca/tratamiento farmacológico , Piel/patología , Úlcera Cutánea/tratamiento farmacológico , Úlcera Cutánea/patología
11.
Dermatol Online J ; 25(5)2019 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-31220904

RESUMEN

Cowden syndrome (CS) is an infrequent genodermatosis caused by mutations in the phosphatase and tensin homolog (PTEN) gene in the majority of cases. As such, it belongs to the PTEN hamartoma tumor syndrome spectrum. This disease has a variable clinical expression characterized by the development of multiple hamartomatous tumors in different organs, usually during the second and third decades of life, and a high cumulative risk of several malignancies. We present a case of Cowden syndrome with late diagnosis presenting with a florid dermatological expression and multiple benign tumors, but no malignancies. A novel PTEN mutation was identified.


Asunto(s)
Fibroma/genética , Síndrome de Hamartoma Múltiple/genética , Neoplasias de la Boca/genética , Fosfohidrolasa PTEN/genética , Neoplasias Cutáneas/genética , Femenino , Fibroma/diagnóstico , Fibroma/etiología , Fibroma/patología , Folículo Piloso , Síndrome de Hamartoma Múltiple/complicaciones , Síndrome de Hamartoma Múltiple/diagnóstico , Síndrome de Hamartoma Múltiple/patología , Humanos , Persona de Mediana Edad , Neoplasias de la Boca/diagnóstico , Neoplasias de la Boca/etiología , Neoplasias de la Boca/patología , Mutación , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/patología
12.
Dermatol Online J ; 25(4)2019 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-31046917

RESUMEN

Palmoplantar psoriasis is a particularly challenging variant of psoriasis. Psoriasis at this location has a significant impact on health-related quality of life and is often recalcitrant. However, difficult cases may respond to biologic therapies. Paradoxical reactions during treatment with biological agents have been described, mostly during anti-tumor necrosis factor therapy. These typically present as a change in morphology or distribution of lesions. We present a patient with palmoplantar psoriasis treated with ixekizumab who achieved a favorable response that was coupled with a rare paradoxical reaction, reversed plantar involvement. The reason for this phenomenon and its clinical course are uncertain, but these new lesions are proving recalcitrant to complementary therapies. Provided the increasingly widespread use of biologic therapies, the incidence and diversity of paradoxical reactions are expected to increase.


Asunto(s)
Anticuerpos Monoclonales Humanizados/efectos adversos , Fármacos Dermatológicos/efectos adversos , Dermatosis del Pie/inducido químicamente , Psoriasis/inducido químicamente , Psoriasis/tratamiento farmacológico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Fármacos Dermatológicos/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad
13.
Dermatol Online J ; 25(10)2019 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-31735014

RESUMEN

Apocrine hidrocystoma is a rare, benign, cystic tumor of the apocrine sweat glands. They are most commonly located around the eyes and may also be found on the scalp and neck. However, despite the fact that the nipple and areola contain numerous apocrine sweet glands, apocrine hydrocystomas have not been described previously in this area to the best of our knowledge. We report the first case of this cyst in this unsual location.


Asunto(s)
Glándulas Apocrinas/patología , Pezones/patología , Neoplasias de las Glándulas Sudoríparas/patología , Adulto , Femenino , Humanos , Pezones/diagnóstico por imagen , Neoplasias de las Glándulas Sudoríparas/diagnóstico por imagen , Ultrasonografía Mamaria
20.
Skin Appendage Disord ; 8(6): 486-491, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36407646

RESUMEN

Introduction: Refractory cases of alopecia areata (AA) may be considered a therapeutic challenge. Intralesional methotrexate (IL-MTX) has been used in other dermatological diseases rather than AA. Likewise, its topical use as an immunosuppressant drug may be of interest for the control of the lymphoid infiltrate in AA. On the other hand, the use of fractional ablative laser is supported in literature as an alternative or complementary treatment in AA, whilst the generation of columns of thermal damage may favour the migration of cells and cytokines that are beneficial. Case Presentation: In this paper, we present 2 cases in which IL-MTX and ablative fractional CO2 laser were combined with excellent outcomes. Conclusion: Previous research encompasses a total of 23 patients. Most patients presented with patchy AA. The doses administered ranged from 2.5 to 50 mg with an average frequency of 3 weeks. On average, most patients required a minimum of 3 sessions. One case employed 1% topical methotrexate ointment. Adverse local events were mild and transient. In conclusion, the concomitant application of these treatments has not been reported previously. Specific recommendations relating to the appropriate dosing of the drug, frequency of administration, and requirements for analytical control studies should be determined in further studies.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA